Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2008
11/26/2008CN101313061A Method of expanding double negative t cells
11/26/2008CN101312766A Treatment of sub-gingival pocket infections
11/26/2008CN101312732A Method of preventing oral staining
11/26/2008CN101312657A Additive for animal feed
11/26/2008CN101311270A Eucaryon expression vector capable of inducing cell immunological response and vaccine thereof
11/26/2008CN101311193A Complexes using recombined triple helix support as base
11/26/2008CN101311190A Antigen epitope for exciting protective immunity against tubercle bacillus of human body and uses thereof
11/26/2008CN101311189A Antigen epitope for exciting protective immunity against tubercle bacillus of human body and uses thereof
11/26/2008CN101310769A Multivalent DTP-POLIO vaccines
11/26/2008CN101310768A Medicine composition for treating hepatic disease and use thereof
11/26/2008CN101310757A Plaster for treating tinea corporis and tinea on manus and pedes
11/26/2008CN101310752A Oral traditional Chinese medicine granule for killing virus, adjusting incretion and treating skin disease
11/26/2008CN101310734A Chinese and western combine compound uterus perfusate for treating cow endometritis
11/26/2008CN101310731A Radix bupleuri extract and antibiotic use thereof
11/26/2008CN101310727A Alcohol-containing chlorhexidine iodine disinfectant and preparation method thereof
11/26/2008CN101310726A Alcohol-containing polyhexamethylguanidine iodine disinfectant and preparation method thereof
11/26/2008CN101310702A Emulsion type gel preparation containing chlorhexidine and alcohol
11/26/2008CN100438211C Method and unit for beam control of antenna array
11/26/2008CN100436462C Reaction method of biological alkali, reaction product and use thereof
11/26/2008CN100436456C Imidazo [4,5-b] pyridiniummethyl-containing cephem compounds having broad antibacterial spectrum
11/26/2008CN100436452C Pyrazole compounds useful as protein kinase inhibitors
11/26/2008CN100436449C Preparation of pharmaceutical salts of 4((z)-(4-bromophenyl)(ethoxyimino)methyl)-1'-((2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl)-4'-methyl-1,4'bipiperidine as ccr5-antagonists for the treatment of aid
11/26/2008CN100435847C Continuing release recipe of containing infusible basic remedy
11/26/2008CN100435846C Synthetic peptide vaccines for foot-and-mouth disease
11/26/2008CN100435843C Compsns. of thymopentin and interferon
11/26/2008CN100435822C Oral liquor for clearing wart
11/26/2008CN100435814C Scullcap stem and leaf injection powder and its preparing method
11/26/2008CN100435806C Anionic polymers as toxin binders and antibacterial agents
11/26/2008CN100435805C Use of polysaccharose sulfate for preparing medicine against grippal virus
11/26/2008CN100435804C Oral preparation of quick releasing stavudine, and producing method
11/26/2008CN100435797C Oral quick release preparation of indinavir, and preparing method
11/26/2008CN100435791C Solid bicyclic alcohol dispersion
11/26/2008CN100435786C Application of hypericin in preparing RNA virus resisting medicine
11/25/2008US7456168 2-(pyridin-2-ylamino)-pyrido[2,3, d]pyrimidin-7-ones
11/25/2008US7456167 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
11/25/2008US7456166 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
11/25/2008US7456165 Activity against hepatitis C virus; for example, 13-cyclohexyl-6-(1H-tetrazol-5-yl)-7H-indolo[2,1-a][2]benzazepine-10-carboxylic acid, methyl ester
11/25/2008US7456158 4-dedimethylaminotetracycline derivatives
11/25/2008US7456155 2′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
11/25/2008US7456018 Human hepatoma lines, methods for obtaining same and uses thereof
11/25/2008US7455855 Obtained by reacting polyalkylene glycol or a reactive derivative, a phospholipid and a drug with each other to form covalent bonds to form a delivery substance
11/25/2008US7455846 Immune potentiating compositions of cancer cells
11/25/2008US7455155 Impact absorbent assembly in slope protection systems
11/25/2008CA2433878C Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
11/25/2008CA2433032C Sustained release drug delivery devices with coated drug cores
11/25/2008CA2414146C Substituted benzamides for immune enhancement and for the treatment of cancer, infection and manic-depressive illness
11/25/2008CA2376760C Quinolinecarboxylic acid derivative or salts thereof
11/25/2008CA2375549C Delivery system for biological material
11/25/2008CA2375364C Process for preparing 6-o-alkenyl-substituted erythromycin derivatives
11/25/2008CA2370565C Dermally applicable vitamin d-containing pharmaceutical compositions
11/25/2008CA2361318C Novel nucleosides and oligonucleotide analogues
11/25/2008CA2318579C Nitrogen-containing heterocyclic compounds and medicaments containing the compounds
11/25/2008CA2271136C Novel pyridonecarboxylic acid derivatives or salts thereof and drugs containing the same as the active ingredient
11/20/2008WO2008141227A1 Novel peptide inhibitors of hepatitis c virus replication
11/20/2008WO2008141079A1 Tetrahydrofuro [3 4-d] dioxolane compounds for use in the treatment of viral infections and cancer
11/20/2008WO2008141010A2 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof
11/20/2008WO2008140834A2 Novel antimicrobial peptides
11/20/2008WO2008140622A2 Modified polymerases and attenuated viruses and methods of use thereof
11/20/2008WO2008140602A2 USE OF ANTAGONISTS OF THE INTERACTION BETWEEN HIV GP120 AND α4β7 INTEGRIN
11/20/2008WO2008140579A2 Induction of broadly reactive neutralizing antibodies by focusing the immune response on v3 epitopes of the hiv-1 gp120 envelope
11/20/2008WO2008140345A1 Glycyrrhizic acid di- and trinicotinates and an inhibitor of the reproduction of human immunodeficiency virus
11/20/2008WO2008140302A1 Polymorphic forms of tenofovir disoproxil fumarate
11/20/2008WO2008139938A1 Double-stranded nucleic acid molecule targeting for human papilloma virus type-16 gene, and pharmaceutical agent comprising the molecule
11/20/2008WO2008139402A2 A method of inhibiting hiv replication
11/20/2008WO2008139288A2 Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials
11/20/2008WO2008139241A1 Uses of north american ginseng fractions for treating leukemia
11/20/2008WO2008138943A2 Prophylactic and therapeutic use of sirtuin inhibitors in tnf-alpha mediated pathologies
11/20/2008WO2008138878A2 Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
11/20/2008WO2008138658A2 Pharmaceutical compounds comprising abasic oligonucleotides
11/20/2008WO2008138590A1 Composition containing hcmv particles
11/20/2008WO2008138516A1 (s,r)-3-phenyl-4,5 dihydro-5-isoxazole acetic acid-nitric oxide and use thereof as anti-cancer and antiviral agent
11/20/2008WO2008138229A1 Recombinant protein expression system with enhanced yield and immunogenicity
11/20/2008WO2008138214A1 A method for activation and expansion of lymphocytes with high efficiency and the culture sysytem thereof
11/20/2008WO2008138120A1 Avian influenza h5n1 hemagglutilin pseudotyped lentiviral vector system for rapid identification of antivirals and neutralizing polypeptides
11/20/2008WO2008138079A2 Use of nucleoside derivatives as anti-koi herpes virus in fish
11/20/2008WO2008138072A1 Treatment and prevention of influenza
11/20/2008WO2008138043A1 The use of oestrogen applied to the penis to reduce hiv infections
11/20/2008WO2008117225A3 New imidazolo-heteroaryl derivatives with antibacterial properties
11/20/2008WO2008117079B1 Antimicrobial compounds based upon 4-aminoquinoline
11/20/2008WO2008106226A3 Macrolide compounds and methods of making and using the same
11/20/2008WO2008106074A3 Methods of treating infection
11/20/2008WO2008095479A3 Use of a highly emulsified silicone oil (hes) for the production of a medicament
11/20/2008WO2008093280A3 Anti-idiotype monoclonal antibodies as mimotopes of the hiv gp120 antigen
11/20/2008WO2008077956A3 Oligonucleotide-, protein and/or peptide-polymer conjugates
11/20/2008WO2008068533A3 Antimicrobial composition
11/20/2008WO2008058993A3 Use of alpha ketogluaric acid for the treatment of infection with h. pylori
11/20/2008WO2007147404A3 Pharmaceutical composition with an extracellular polyanion from arthrospira
11/20/2008WO2007131168A3 Inhibitors of secretion of hepatitis b virus antigens for treatment of a chronic hepatitis virus
11/20/2008WO2007129019A8 Sulfonamide compounds useful as edg receptor modulators
11/20/2008WO2003061577A8 Polyalkylene glycol with moiety for conjugating biologically active compound
11/20/2008US20080289065 Peptide Aptamers That Bind to the Rep Proteins of Ssdna Viruses
11/20/2008US20080288627 Storage network and method for storage network device mapping
11/20/2008US20080287538 Antimicrobial Compositions and Methods
11/20/2008US20080287532 Oxacyclopentene-2 derivatives
11/20/2008US20080287527 Comprising hydroxymorusin, Cortex Mori (White Mulberry root-bark), for use in manufacturing antibacterial medicaments or oral care products; treatment of caries and periodontal disease
11/20/2008US20080287526 Pharmaceuticals for treating or preventing oral diseases
11/20/2008US20080287522 reduced or no emetogenic effects ; benzylated phosphodiesterase 4 inhibitors; e.g. Rolipram, Ariflo, Arofylline; preparation by benzylation using benzyl bromide or a derivative; antiinflammatory agents; to treat autoimmune diseases; cystic fibrosis
11/20/2008US20080287516 Phenyl-Substituted Pyrrolidones
11/20/2008US20080287496 1-Oxo- and 1,3-dioxoisoindolines and method of reducing inflammatory cytokine levels
11/20/2008US20080287488 Use of a Sulfonamide Compound For Improving the Pharmacokinetics of a Drug
1 ... 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 ... 1798